01
Cash & equivalents decreased 94.5%
Cash & equivalents changed -94.5% from the comparable as-filed period.
$14.3M→$779,000Comparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTTempest Therapeutics, Inc.'s latest supported as-filed period reports revenue of $55,000. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -94.5% from the comparable as-filed period.
Net income changed +33.4% from the comparable as-filed period.
Operating income changed +34.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
TPST · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-363695SEC ↗8-KAug 18, 2026Period Aug 17, 20260001193125-26-355550SEC ↗10-QAug 13, 2026Period Jun 30, 20260001193125-26-349381SEC ↗8-KAug 13, 2026Period Aug 13, 20260001193125-26-349374SEC ↗8-KAug 13, 2026Period Aug 13, 20260001193125-26-349334SEC ↗8-KJul 28, 2026Period Jul 27, 20260001193125-26-321176SEC ↗8-KJul 22, 2026Period Jul 17, 20260001193125-26-312391SEC ↗4Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Mar 24, 2026Filed Jun 23, 2026 | Angel MatthewCEO and President | Open Market PurchaseIndirect | 231,482 | $2 | $500,001 | Form 4 ↗ |
| Mar 24, 2026Filed Jun 23, 2026 | Angel MatthewCEO and President | Open Market PurchaseIndirect | 231,482 | — | — | Form 4 ↗ |
| Mar 24, 2026Filed Jun 23, 2026 | Angel MatthewCEO and President | Open Market PurchaseIndirect | 231,482 | — | — | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Stock-based compensation changed -110.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-279703